AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA grants fast track designation for MedPulser Electroporation Therapy System.

Vaccine Weekly

| July 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Genetronics Biomedical Corp. (GEB) has been granted a fast track designation by the U.S. Food and Drug Administration for its MedPulser Electroporation System clinical development program for patients with head and neck cancer.

The fast track designation is intended to facilitate development and expedite the review of new therapies that are intended to treat serious or life-threatening conditions and demonstrate the potential to address unmet medical needs so that an approved product can reach the market expeditiously.

Genetronics is currently conducting two phase III pivotal studies comparing the MedPulser System in combination with the cancer drug, bleomycin, versus surgical resection in patients with recurrent or second primary squamous cell ...

Related articles from newspapers, magazines, journals, and more
FDA grants fast track designation for MedPulser Electroporation Therapy System.
Newspaper article from: Cancer Weekly July 6, 2004 700+ words
...been granted a fast track designation...Administration for its MedPulser Electroporation System clinical...cancer. The fast track designation...needs. The fast track designation of our MedPulser Electroporation Therapy System...
Genetronics commences European pre-sale skin cancer study using its MedPulser...
News wire article from: Asia Africa Intelligence Wire November 9, 2004 700+ words
...European pre-sales clinical study using its MedPulser Electroporation Therapy System. This pre-marketing Phase...in a number of hospitals in Europe. The MedPulser Electroporation Therapy System is designed to treat solid...
Genetronics Biomedical.(Product briefs)(MedPulser Electroporation Therapy...
Newspaper article from: The BBI Newsletter January 1, 2005 700+ words
...solid tumors requiring potentially disfiguring surgical treatment in a European clinical study using its MedPulser Electroporation Therapy System. This premarketing Phase IV study is a multi-center, open-label study that will measure...
Genetronics Receives CE Mark Approval for MedPulser Electroporation System to...
Press release article from: PR Newswire March 17, 1999 700+ words
First Milestone in Agreement With Ethicon, Inc. SAN DIEGO, March 17 /PRNewswire/ -- Genetronics Biomedical Ltd. (Amex: GEB; Toronto) today announced approval to affix the CE Mark to the proprietary MedPulser(R) electroporation device used in Electroporation Therapy (EPT) treatment of solid tumors.
Genetronics Granted FDA Fast Track Designation for Its MedPulser(R)...
Press release article from: PR Newswire June 7, 2004 700+ words
...been granted a fast track designation...Administration for its MedPulser Electroporation System clinical...cancer. The fast track designation...needs. The fast track designation of our MedPulser Electroporation Therapy System...
Genetronics Appoints Senior Pharmaceutical Executive Walter Singleton as Vice...
Press release article from: PR Newswire September 20, 2004 700+ words
...diagnosed primary and recurrent head and neck cancers. The MedPulser Electroporation Therapy System is an electroporation device that significantly...and neck. The FDA has also granted the MedPulser System fast track designation. About Genetronics Biomedical Corporation...
H Lee Moffitt Cancer Center and Genetronics initiate Phase I clinical trial in...
News wire article from: Asia Africa Intelligence Wire January 13, 2005 700+ words
...an immune response that will eliminate the cancer. The MedPulser electroporation therapy system significantly enhances local cellular uptake...cell carcinomas of the head and neck. The FDA granted fast track status for these trials. Genetronics Biomedical Corp...
Studies Suggest Alternatives to Surgery are Needed in Treatment of Head and...
Press release article from: PR Newswire September 15, 2004 700+ words
...diagnosed primary and recurrent head and neck cancers. The MedPulser Electroporation Therapy System is an electroporation device that significantly...head and neck. The FDA also granted the MedPulser System fast track designation. About Genetronics Biomedical Corporation...
Fast track down to the wire. (extending the fast track authority for carriers)
Magazine article from: American Shipper Warren, William J. June 1, 1991 700+ words
Carriers say 'yes' to fast track but absolutely 'no' to putting shipping...request for a two-year extension of fast-track authority. For George Bush no news will...request by June 1, according to the fast-track statute, otherwise the extension automatically...
FAST TRACK TEACHING GRADUATES CONGRATULATED.
News wire article from: Europe Intelligence Wire March 24, 2006 700+ words
...AND SKILLS 2006/0044 24 March 2006 FAST TRACK TEACHING 'GRADUATES' CONGRATULATED...Twenty-three 'graduates' of the Fast Track Teaching programme were congratulated...play in schools throughout England. Fast Track Teaching is a leadership development...
For more facts and information, see all results

Source: HighBeam Research, FDA grants fast track designation for MedPulser Electroporation...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA